Weiya Cao

989 total citations · 1 hit paper
27 papers, 696 citations indexed

About

Weiya Cao is a scholar working on Molecular Biology, Oncology and Epidemiology. According to data from OpenAlex, Weiya Cao has authored 27 papers receiving a total of 696 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 6 papers in Oncology and 6 papers in Epidemiology. Recurrent topics in Weiya Cao's work include Curcumin's Biomedical Applications (6 papers), PI3K/AKT/mTOR signaling in cancer (6 papers) and Autophagy in Disease and Therapy (4 papers). Weiya Cao is often cited by papers focused on Curcumin's Biomedical Applications (6 papers), PI3K/AKT/mTOR signaling in cancer (6 papers) and Autophagy in Disease and Therapy (4 papers). Weiya Cao collaborates with scholars based in China and Poland. Weiya Cao's co-authors include Dongli Cao, Jinhong Li, Pan Yu, Yinci Zhang, Ruyue Xu, Yongfang Ma, Amin Li, Shuping Zhou, Song Li and Xinkuang Liu and has published in prestigious journals such as PLoS ONE, Scientific Reports and Molecules.

In The Last Decade

Weiya Cao

23 papers receiving 690 citations

Hit Papers

An overview of autophagy: Mechanism, regulation and resea... 2021 2026 2022 2024 2021 50 100 150 200 250
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. An overview of autophagy: Mechanism, regulation and research progress
    2021 289 citations Weiya Cao, Jinhong Li et al. Bulletin du Cancer profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Weiya Cao China 13 355 215 113 112 78 27 696
Jingxin Mao China 15 320 0.9× 158 0.7× 65 0.6× 92 0.8× 51 0.7× 62 764
Weifeng Huang China 17 351 1.0× 137 0.6× 55 0.5× 102 0.9× 97 1.2× 38 787
Yifan Yu China 15 377 1.1× 98 0.5× 101 0.9× 134 1.2× 78 1.0× 40 679
Junjie Hu China 17 420 1.2× 140 0.7× 61 0.5× 234 2.1× 76 1.0× 56 815
Julio Isael Pérez‐Carreón Mexico 17 468 1.3× 97 0.5× 61 0.5× 141 1.3× 40 0.5× 47 772
Nannan Liu China 15 267 0.8× 162 0.8× 51 0.5× 68 0.6× 33 0.4× 48 656
Yang Ke China 14 250 0.7× 112 0.5× 74 0.7× 126 1.1× 59 0.8× 34 617
Min Gi Japan 17 381 1.1× 109 0.5× 50 0.4× 162 1.4× 56 0.7× 72 805
Wenwen Wang China 17 329 0.9× 214 1.0× 45 0.4× 82 0.7× 89 1.1× 32 932
Nisansala Chandimali South Korea 14 300 0.8× 109 0.5× 38 0.3× 106 0.9× 117 1.5× 34 654

Countries citing papers authored by Weiya Cao

Since Specialization
Citations

This map shows the geographic impact of Weiya Cao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weiya Cao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weiya Cao more than expected).

Fields of papers citing papers by Weiya Cao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Weiya Cao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weiya Cao. The network helps show where Weiya Cao may publish in the future.

Co-authorship network of co-authors of Weiya Cao

This figure shows the co-authorship network connecting the top 25 collaborators of Weiya Cao. A scholar is included among the top collaborators of Weiya Cao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Weiya Cao. Weiya Cao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Cao, Weiya, Bing Li, Haibo Jin, et al.. (2025). S100a8 inhibitor Paquinimod attenuates coal dust-induced pulmonary fibrosis via blocking neutrophils-S100a8-Tlr4-macrophages signaling axis. International Immunopharmacology. 161. 115020–115020.
4.
5.
Cao, Weiya, et al.. (2025). Synthesis and antitumor evaluation of amino acid conjugates of monocarbonyl curcumin in hepatocellular carcinoma cell. Scientific Reports. 15(1). 8181–8181. 2 indexed citations
6.
Yu, Pan, et al.. (2024). A7, A Novel Analog of Curcumin, Induces Cell Apoptosis Through Suppressing TGF-βR/MEK/ERK Pathway in A549 Cells. Pharmaceutical Chemistry Journal. 58(5). 793–800. 1 indexed citations
7.
Cao, Weiya, et al.. (2023). Discovery of Novel Mono-Carbonyl Curcumin Derivatives as Potential Anti-Hepatoma Agents. Molecules. 28(19). 6796–6796. 5 indexed citations
8.
Yu, Pan, Weiya Cao, & Yuan Wang. (2023). Dynamics simulation and in vitro studies of betulinic acid derivative with liver X receptor. Journal of Biomolecular Structure and Dynamics. 42(13). 7014–7023. 4 indexed citations
9.
Yu, Pan, et al.. (2022). Design, synthesis and antitumor evaluation of novel quinazoline analogs in hepatocellular carcinoma cell. Journal of Molecular Structure. 1268. 133718–133718. 7 indexed citations
10.
Yu, Pan, Weiya Cao, Lin-Guo Zhao, et al.. (2022). Design, Synthesis, and Antitumor Evaluation of Novel Mono-Carbonyl Curcumin Analogs in Hepatocellular Carcinoma Cell. Pharmaceuticals. 15(8). 950–950. 15 indexed citations
11.
Cao, Weiya, Xueke Liu, Amin Li, et al.. (2021). BEZ235 Increases the Sensitivity of Hepatocellular Carcinoma to Sorafenib by Inhibiting PI3K/AKT/mTOR and Inducing Autophagy. BioMed Research International. 2021(1). 5556306–5556306. 18 indexed citations
12.
Cao, Weiya, et al.. (2021). An overview of autophagy: Mechanism, regulation and research progress. Bulletin du Cancer. 108(3). 304–322. 289 indexed citations breakdown →
13.
Cao, Weiya, Yinci Zhang, Amin Li, et al.. (2021). Curcumin reverses hepatic epithelial mesenchymal transition induced by trichloroethylene by inhibiting IL-6R/STAT3. Toxicology Mechanisms and Methods. 31(8). 589–599. 19 indexed citations
14.
Xu, Ruyue, Yinci Zhang, Amin Li, et al.. (2021). LY‑294002 enhances the chemosensitivity of liver cancer to oxaliplatin by blocking the PI3K/AKT/HIF‑1α pathway. Molecular Medicine Reports. 24(1). 22 indexed citations
15.
Ma, Yongfang, Ruyue Xu, Xueke Liu, et al.. (2021). LY3214996 relieves acquired resistance to sorafenib in hepatocellular carcinoma cells. International Journal of Medical Sciences. 18(6). 1456–1464. 28 indexed citations
16.
Li, Amin, Weiya Cao, Xueke Liu, et al.. (2020). Gefitinib sensitization of cisplatin-resistant wild-type EGFR non-small cell lung cancer cells. Journal of Cancer Research and Clinical Oncology. 146(7). 1737–1749. 14 indexed citations
17.
Shen, Jing, Yongfang Ma, Ruyue Xu, et al.. (2020). hGC33-Modified and Sorafenib-Loaded Nanoparticles have a Synergistic Anti-Hepatoma Effect by Inhibiting Wnt Signaling Pathway. Nanoscale Research Letters. 15(1). 220–220. 17 indexed citations
18.
Li, Amin, Weiya Cao, Xueke Liu, et al.. (2020). Increased efficacy of gefitinib on cisplatin-resistant wild-type epidermal growth factor receptor non-small cell lung cancer cells. Translational Cancer Research. 9(9). 5473–5483. 1 indexed citations
19.
Wang, Jianwen, et al.. (2019). Expression of vascular endothelial growth factor and its vital catalytic role in promotion of invasion and metastasis of hepatocellular carcinoma cells. Zhonghua weishengwuxue he mianyixue zazhi. 39(1). 73–78. 1 indexed citations
20.
Wang, Jian, et al.. (2018). Occult HBV Infection in Peripheral Blood Neutrophils of Chronic Hepatitis B and Its Effects on Expression of CXCR1, CXCR2, CXCL8 and CD16. Nanoscience and Nanotechnology Letters. 10(2). 244–251. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jingxin Mao Breakdown of academic impact, for papers by Weifeng Huang Breakdown of academic impact, for papers by Yifan Yu Breakdown of academic impact, for papers by Junjie Hu Breakdown of academic impact, for papers by Julio Isael Pérez‐Carreón Breakdown of academic impact, for papers by Nannan Liu Breakdown of academic impact, for papers by Yang Ke Breakdown of academic impact, for papers by Min Gi Breakdown of academic impact, for papers by Wenwen Wang Breakdown of academic impact, for papers by Nisansala Chandimali
Rankless by CCL
2026